Radiation and Orthopedic Safety in the Cath Lab

Radiation and Orthopedic Safety in the Cath Lab—We Can Do Both

Overview

Allison G. Dupont, MD, FSCAI

Moderator and Speaker

James B. Hermiller, MD, FSCAI

Moderator and Speaker

Islam Abudayyeh, MD, FSCAI

Speaker

Anna Bortnick, MD, PhD, FSCAI

Speaker

Arnold H. Seto, MD, MPA, FSCAI

Speaker

Welcome and Overview, Allison G. Dupont, MD, FSCAI

Scope of the Problem and What SCAI’s Doing About It, James B. Hermiller, MD, FSCAI

What’s in the Toolkit? Radiation Reduction, Shielding Tools, and Advanced Imaging Techniques, Arnold H. Seto, MD, MPA, FSCAI

The Economic Argument: How to Influence Administration to Invest in the Health of Cath Lab Workers, Anna Bortnick, MD, PhD, FSCAI

Practical Considerations for Implementation: Cath Lab Director’s Perspective, Islam Abudayyeh, MD, FSCAI

Acknowledgment of Commercial Support

This activity is supported by unrestricted educational grants from Burlington Medical, Canon Medical Systems, Egg Medical, Omega Medical Imaging, Protego, Radiaction, Rampartic, Salus Scientific, and Texrayl.

Learning Objectives

Upon completion of this activity, participants will be able to:

1. Review how to implement enhanced radiation protection devices.

2. Describe strategies to support and advocate for individual physicians and practices in gaining hospital administration financial support for these new technologies.

3. Examine cath lab imaging systems that minimize radiation exposure to patients, physicians and staff by incorporating dose-reduction hardware.

4. Discuss new radiation shielding technologies that allow for lighter lead aprons or no lead aprons with minimal exposure to staff and operators.

5. Review the evidence demonstrating the occupational hazards of the standard cardiac cath lab, including the risks of radiation exposure, the high frequency of orthopedic/spinal injury, and the deleterious impact on physician and staff wellness.

Disclosures

PLANNERS

Anna Bortnick, James Hermiller: No relevant financial relationships with ineligible companies.

FACULTY 

Islam Abudayyeh, Anna Bortnick, Allison Dupont, James Hermiller: No relevant financial relationships with ineligible companies.

ArnoldSeto: GE Healthcare - Speaker; Summacor and Frond Medical - Consulting, Stocks.

REVIEWER 

Binita Shah: No financial relationships with ineligible companies.

SCAI STAFF

Laura Porter: No financial relationships with ineligible companies

Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Activity Timeline
Record date: May 3, 2025
Publish date: June 30, 2025
Retire date: April 17, 2026

SCAI's Independent Content

As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.

Planning Process
SCAI activities are developed by the SCAI planners prior to and independent of commercial support. Members of the Program Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.

Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins. 

Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations.

All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.

All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.

SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. SCAI's educational content is free of marketing or sales of products or services.

Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education. 

SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.

Summary

Availability:

On-Demand

Access expires on Apr 17, 2026

Cost:

FREE

Credit Offered:

1 CME Credit

1 ABIM-MOC Point

1 ABP-MOC Point

1 Participation Credit